The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Abstract
The beneficial actions of nonsteroidal anti‐inflammatory drugs (NSAIDs) have been linked to their ability to inhibit inducible COX‐2 at sites of inflammation, and their side effects (e.g., gastric damage) to inhibition of constitutive COX‐1. Selective inhibitors of COX‐2, such as celecoxib, etoricoxib, lumiracoxib, rofecoxib, and valdecoxib have been developed and the greatest recent growth in our knowledge in this area has been come from the clinical use of these compounds. Although clinical data indicate that COX‐2 selectivity is associated with a reduction in severe gastrointestinal events, they also reveal there are roles for constitutive COX‐2 within tissues such as the brain, kidney, pancreas, intestine, and blood vessels. We now better understand the roles of COX‐1 and COX‐2 in functions as disparate as the perception of pain and the progression of cancers. Clinical use of COX‐2‐selective compounds has ignited strong debates regarding potential side effects, most notably those within the cardiovascular system such as myocardial infarctions, strokes, and elevation in blood pressure. This review will discuss how the latest studies help us understand the roles of COX‐1 and COX‐2 and what clinically proven benefits the newer generation of COX‐2‐selective inhibitors offer.—Warner, T. D., Mitchell, J. A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 18, 790–804 (2004)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Subbaramaiah, K., Lin, D. T., Hart, J. C., & Dannenberg, A. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007237200 · Cited by 275
RetractedBombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Self-citationThun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,281
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
Solomon, D. H., Karlson, E. W., Rimm, E. B., Cannuscio, C. C., Mandl, L. A., Manson, J. E., Stampfer, M. J., & Curhan, G. C. (2003) · Circulation · doi:10.1161/01.cir.0000054612.26458.b2 · Cited by 1,246
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
Wallace, J. L., McKnight, W., Reuter, B. K., & Vergnolle, N. (2000) · Gastroenterology · doi:10.1053/gast.2000.16510 · Cited by 705
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
Tucker, O., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., et al. (1999) · PubMed · Cited by 692
Talley, J. J., Brown, D. L., Carter, J. S., Graneto, M. J., Koboldt, C. M., Masferrer, J. L., Perkins, W. E., Rogers, R. S., Shaffer, A. F., Zhang, Y. Y., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990577v · Cited by 638
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Chan, F. K. L., Hung, L. C. T., Suen, B. Y., Wu, J. C. Y., Lee, K. C., Leung, V. K. S., Hui, A. J., To, K. F., Leung, W. K., Wong, V. W. S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021907 · Cited by 555
Cyclo-Oxygenase 2 Function Is Essential for Bone Fracture Healing
Simon, A. M., Manigrasso, M. B., & O'Connor, J. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.963 · Cited by 530
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
Ray, W. A., Stein, C. M., Daugherty, J. R., Hall, K., Arbogast, P. G., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11131-7 · Cited by 503
Riendeau, D., Percival, M. D., Brideau, C., Charleson, S., Dubé, D., Ethier, D., Falgueyret, J.-P., Friesen, R. W., Gordon, R., Greig, G., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38776-2 · Cited by 460
Phillips, R. K. S., Wallace, M. H., Lynch, P. M., Hawk, E., Gordon, G. B., Saunders, B. P., Wakabayashi, N., Shen, Y., Zimmerman, S., Godio, L., et al. (2002) · Gut · doi:10.1136/gut.50.6.857 · Cited by 441
Effect of ibuprofen on cardioprotective effect of aspirin
MacDonald, T., & Wei, L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12509-3 · Cited by 419
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Jüni, P., Rutjes, A. W., & Dieppe, P. A. (2002) · BMJ · doi:10.1136/bmj.324.7349.1287 · Cited by 396
Buvanendran, A., Kroin, J. S., Tuman, K. J., Lubenow, T. R., Elmofty, D., Moric, M., & Rosenberg, A. G. (2003) · JAMA · doi:10.1001/jama.290.18.2411 · Cited by 389
Leese, P. T., Hubbard, R. C., Karim, A., Isakson, P. C., Yu, S. S., & Geis, G. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008766 · Cited by 371
Nash, G., Turner, L., Scully, M., & Kakkar, A. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00789-1 · Cited by 366
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Chenevard, R., Hürlimann, D., Béchir, M., Enseleit, F., Spieker, L., Hermann, M., Riesen, W., Gay, S., Gay, R. E., Neidhart, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051361.69808.3a · Cited by 358
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
Konstam, M. A., Weir, M. R., Reicin, A., Shapiro, D., Sperling, R. S., Barr, E., & Gertz, B. J. (2001) · Circulation · doi:10.1161/hc4401.100078 · Cited by 352
Bensen, W. G., Fiechtner, J. J., McMillen, J. I., Zhao, W. W., Yu, S. S., Woods, E. M., Hubbard, R. C., Isakson, P. C., Verburg, K. M., & Geis, G. S. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.11.1095 · Cited by 348
Buttar, N. S., Wang, K. K., Leontovich, O., Westcott, J. Y., Pacifico, R. J., Anderson, M. A., Krishnadath, K. K., Lutzke, L. S., & Burgart, L. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32371 · Cited by 348
Murakami, M., Kambe, T., Shimbara, S., & Kudo, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3103 · Cited by 348
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Whelton, A., Fort, J. G., Puma, J. A., Normandin, D., Bello, A. E., & Verburg, K. M. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200103000-00003 · Cited by 334
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 322
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Mitchell, J. A., & Warner, T. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702897 · Cited by 321
Self-citationRenal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
Whelton, A., White, W. B., Bello, A. E., Puma, J. A., & Fort, J. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02661-9 · Cited by 310
Fiala, M., Liu, Q. N., Sayre, J., Pop, V., Brahmandam, V., Graves, M. C., & Vinters, H. V. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00994.x · Cited by 307
The Spinal Phospholipase-Cyclooxygenase-Prostanoid Cascade in Nociceptive Processing
Svensson, C. I., & Yaksh, T. L. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.092401.143905 · Cited by 302
Lipocalins as biochemical markers of disease
Xu, S., & Venge, P. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00163-1 · Cited by 285
Mamdani, M., Rochon, P., Juurlink, D. N., Anderson, G. M., Kopp, A., Naglie, G., Austin, P. C., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.481 · Cited by 281
Effects of Celecoxib and Naproxen on Renal Function in the Elderly
Whelton, A., Schulman, G., Wallemark, C., Drower, E. J., Isakson, P. C., Verburg, K. M., & Geis, G. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1465 · Cited by 280
Cannon, G. W., Caldwell, J. R., Holt, P., McLean, B., Seidenberg, B., Bolognese, J., Ehrich, E., Mukhopadhyay, S., & Daniels, B. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<978::aid-anr4>3.0.co;2-0 · Cited by 279
Altorki, N. K., Keresztes, R. S., Port, J. L., Libby, D. M., Korst, R. J., Flieder, D. B., Ferrara, C. A., Yankelevitz, D. F., Subbaramaiah, K., Pasmantier, M. W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.127 · Cited by 275
Yaksh, T. L., Dirig, D. M., Conway, C. M., Svensson, C., Luo, Z. D., & Isakson, P. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05847.2001 · Cited by 270
Watson, D. J., Rhodes, T., Cai, B., & Guess, H. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1105 · Cited by 238
Nonsteroidal Anti-inflammatory Drug Use and Acute Myocardial Infarction
Solomon, D. H., Glynn, R. J., Levin, R., & Avorn, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1099 · Cited by 234
MORRISON, B., CHRISTENSEN, S., YUAN, W., BROWN, J., AMLANI, S., & SEIDENBERG, B. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80016-2 · Cited by 233
White, W. B., Faich, G., Whelton, A., Maurath, C., Ridge, N. J., Verburg, K. M., Geis, G. S., & Lefkowith, J. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02265-2 · Cited by 230
Yang, W.-L. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1379 · Cited by 218
Inducible Cyclooxygenase and Nitric Oxide Synthase
Wu, K. K. (1995) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60669-9 · Cited by 209
Bae, S. H., Jung, E. S., Park, Y. M., Kim, B., Kim, B. K., Kim, D., & Ryu, W. (2001) · PubMed · Cited by 209
Association Between Naproxen Use and Protection Against Acute Myocardial Infarction
Rahme, E., Pilote, L., & LeLorier, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1111 · Cited by 203
Urade, Y., & Eguchi, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00042-4 · Cited by 203
Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma
Stevenson, D. D., & Simon, R. A. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.116290 · Cited by 200
Sabino, M. A. C., Ghilardi, J. R., Jongen, J. L. M., Keyser, C. P., Luger, N. M., Mach, D. B., Peters, C. M., Rogers, S. D., Schwei, M. J., Felipe, C. D., et al. (2002) · PubMed · Cited by 199
Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., & Beauchamp, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6628 · Cited by 196
Boon, E. M. J., Keller, J. J., Wormhoudt, T. A. M., Giardiello, F. M., Offerhaus, G. J. A., van der Neut, R., & Pals, S. T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601505 · Cited by 190
Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma
Szczeklik, A., Nizankowska, E., Bochenek, G., Nagraba, K., Mejza, F., & Swierczynska, M. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01075.x · Cited by 187
Frequency of Analgesic Use and Risk of Hypertension in Younger Women
Curhan, G. C., Willett, W. C., Rosner, B., & Stampfer, M. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2204 · Cited by 179
Sheng, H., Shao, J., & DuBois, R. N. (2001) · PubMed · Cited by 174
COX‐2 selective NSAID decreases bone ingrowth in vivo
Goodman, S., Ma, T., Trindade, M., Ikenoue, T., Matsuura, I., Wong, N., Fox, N., Genovese, M., Regula, D., & Smith, R. L. (2002) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(02)00079-7 · Cited by 174
Reduction of scar formation in full‐thickness wounds with topical celecoxib treatment
Wilgus, T. A., Vodovotz, Y., Vittadini, E., Clubbs, E. A., & Oberyszyn, T. M. (2003) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2003.11106.x · Cited by 170
Pall, M. (2001) · Human Reproduction · doi:10.1093/humrep/16.7.1323 · Cited by 169
Distribution of Cox-1 and Cox-2 in Normal and Inflamed Tissues
Seibert, K., Zhang, Y., Leahy, K., Hauser, S. D., Masferrer, J. L., & Isakson, P. C. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5325-0_24 · Cited by 164
Effect of COX-2-Specific Inhibition on Fracture-Healing in the Rat Femur
Brown, K. M., Saunders, M. M., Kirsch, T., Donahue, H. J., & Reid, S. J. (2004) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200401000-00017 · Cited by 164
Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With Hypertension
Widlansky, M. E., Price, D. T., Gokce, N., Eberhardt, R. T., Duffy, S. J., Holbrook, M., Maxwell, C., Palmisano, J., Keaney, J. F., Morrow, J. D., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000084603.93510.28 · Cited by 158
Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0732com · Cited by 151
Simmons, D. L., Botting, R. M., Robertson, P. M., Madsen, M. L., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3275 · Cited by 149
LISSE, J. R., Perlman, M., Johansson, G. S., Shoemaker, J. R., Schechtman, J., Skalky, C. S., Dixon, M. E., Polis, A. B., Mollen, A., Geba, G. P., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-7-200310070-00005 · Cited by 149
Sarkar, S., Hobson, A. R., Hughes, A. M., Growcott, J., Woolf, C. J., Thompson, D. G., & Aziz, Q. (2003) · Gastroenterology · doi:10.1053/gast.2003.50022 · Cited by 142
Saukkonen, K., Nieminen, O., van Rees, B. P., Vilkki, S., Härkönen, M., Juhola, M. T., Mecklin, J., Sipponen, P., & Ristimaki, A. P. (2001) · PubMed · Cited by 141
Ouellet, M., Riendeau, D., & Percival, M. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543298 · Cited by 139
Watanabe, K. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00044-8 · Cited by 138
Reicin, A. S., Shapiro, D., SPERLING, R. S., Barr, E., & Yu, Q. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02201-9 · Cited by 136
Wick, M. J., Hurteau, G., Dessev, C., Chan, D. C. F., Geraci, M. W., Winn, R. A., Heasley, L. E., & Nemenoff, R. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1207 · Cited by 135
Gretzer, B., Maricic, N., Respondek, M., Schuligoi, R., & Peskar, B. M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703955 · Cited by 133
The safety of celecoxib in patients with aspirin‐sensitive asthma
Woessner, K. M., Simon, R. A., & Stevenson, D. D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10426 · Cited by 131
Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells.
Hara, S., Miyata, A., Yokoyama, C., Inoue, H., Brugger, R., Lottspeich, F., Ullrich, V., & Tanabe, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32104-x · Cited by 130
THE EFFECT OF CYCLOOXYGENASE-2 INHIBITORS ON SPINAL FUSION
LONG, J., Lewis, S. F., Kuklo, T. R., Zhu, Y., & Riew, K. D. (2002) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200210000-00004 · Cited by 123
Marrache, A. M., Gobeil, F., Bernier, S. G., Staňková, J., Rola‐Pleszczynski, M., Choufani, S., Bkaily, G., Bourdeau, A., Sirois, M. G., Vazquez‐Tello, A., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6474 · Cited by 121
Constitutive Cyclooxygenase-2 Expression in Healthy Human and Rabbit Gastric Mucosa
Zimmermann, K. C., Sarbia, M., Schrör, K., & Weber, A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.536 · Cited by 121
A Cyclooxygenase-2 Inhibitor Impairs Ligament Healing in the Rat
Elder, C. L., Dahners, L. E., & Weinhold, P. S. (2001) · The American Journal of Sports Medicine · doi:10.1177/03635465010290062101 · Cited by 117
The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery
Daniels, S. E., Desjardins, P. J., Talwalker, S., Recker, D. P., & Verburg, K. M. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0237 · Cited by 117
LEUNG, A. T., Malmström, K., Gallacher, A., Sarembock, B., Poór, G., Beaulieu, A. D., Castro, R. S., Sanchez, M., & Ng, J. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000282 · Cited by 117
Hoozemans, J. J. M., Brückner, M. K., Rozemüller, A. J. M., Veerhuis, R., Eikelenboom, P., & Arendt, T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.8.678 · Cited by 116
Xiang, Z., Ho, L., Valdellon, J., Borchelt, D., Kelley, K., Spielman, L., Aisen, P. S., & Pasinetti, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00282-2 · Cited by 111
Altman, R., Luciardi, H. L., Muntaner, J. A., Rio, F. D., Berman, S., López, R., & González, C. D. (2002) · Circulation · doi:10.1161/01.cir.0000021599.56755.a1 · Cited by 109
Cyclooxygenases in Reproductive Medicine and Biology
Kniss, D. A. (1999) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(99)00034-9 · Cited by 108
Makarowski, W. S., Zhao, W. W., Bevirt, T., & Recker, D. P. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2001.0510 · Cited by 107
Hunt, R. H., Harper, S. E., Callegari, P., Yu, C., Quan, H., Evans, J. K., James, C., Bowen, B. M., & Rashid, F. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01407.x · Cited by 106
Connolly, E., Harmey, J. H., O’Grady, T. J., Foley, D., Roche‐Nagle, G., Kay, E., & Bouchier‐Hayes, D. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600462 · Cited by 102
Sikes, D. H., Agrawal, N. M., Zhao, W. W., Kent, J. D., Recker, D. P., & Verburg, K. M. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200210000-00011 · Cited by 101
COX-3: in the wrong frame in mind
Dinchuk, J. E., Liu, R. Q., & Trzaskos, J. M. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00268-7 · Cited by 100
Putative Cyclooxygenase-3 Expression in Rat Brain Cells
Kis, B., Snipes, J. A., Isse, T., Nagy, K. A., & Busija, D. W. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000090681.07515.81 · Cited by 97
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
Schwartz, J. I., CHAN, C., Mukhopadhyay, S., MCBRIDE, K., JONES, T., Adcock, S., MORITZ, C., Hedges, J. R., Grasing, K., & DOBRATZ, D. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90087-5 · Cited by 89
Fenwick, S. W., Toogood, G. J., Lodge, J. P. A., & Hull, M. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01061-8 · Cited by 88
Singh, G., Miller, J. D., Huse, D. M., et al. (2003) · PubMed · Cited by 85
Schüller, H., Zhang, L., Weddle, D. L., Castonguay, A., Walker, K., & Miller, M. J. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0365-y · Cited by 84
Clinical pharmacology of etoricoxib: a novel selective COX-2 inhibitor
Patrignani, P., Capone, M. L., & Tacconelli, S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.2.265 · Cited by 84
Blomme, E. A. G., Chinn, K. S., Hardy, M. M., Casler, J. J., Kim, S. H., Opsahl, A., Hall, W. A., Trajković, D., Khan, K. N. M., & Tripp, C. S. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05065.x · Cited by 82
Lazarus, M., Munday, C. J., Eguchi, N., Matsumoto, S., Killian, G. J., Kubata, B. K., & Urade, Y. (2002) · Endocrinology · doi:10.1210/en.143.6.2410 · Cited by 78
Rofecoxib Reduces Polyp Recurrence in Familial Polyposis
Hallak, A., Alon-Baron, L., Shamir, R., Moshkowitz, M., Bulvik, B., Brazowski, E., Halpern, Z., & Arber, N. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1026130623186 · Cited by 77
Jiang, X., Lam, S., Lin, M. C. M., Shi-hu, J., Kung, H., Slosberg, E. D., Soh, J. W., Weinstein, I. B., & Wong, B. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205778 · Cited by 76
Valdecoxib, a Cyclooxygenase-2-Specific Inhibitor, Is Effective in Treating Primary Dysmenorrhea
Daniels, S., Talwalker, S., Torri, S., Snabes, M. C., Recker, D. P., & Verburg, K. M. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02085-9 · Cited by 76
Selective COX‐2 inhibitors and human inflammatory bowel disease
Mccartney, Mitchell, Fairclough, et al. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00585.x · Cited by 74
Launer, L. J. (2003) · Drugs · doi:10.2165/00003495-200363080-00001 · Cited by 70
Greenberg, H. E., Gottesdiener, K. M., Huntington, M. F., Wong, P., Larson, P., Wildonger, L., Gillen, L. P., Dorval, E. P., & Waldman, S. A. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001224 · Cited by 69
Ibuki, T., Matsumura, K., Yamazaki, Y., Nozaki, T., Tanaka, Y., & Kobayashi, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01848.x · Cited by 66
Celecoxib Does Not Affect the Antiplatelet Activity of Aspirin in Healthy Volunteers
Wilner, K. D., Rushing, M., Walden, C. E., et al. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127000204200910 · Cited by 64
Becerra, C. R., Frenkel, E. P., Ashfaq, R., & Gaynor, R. B. (2003) · International Journal of Cancer · doi:10.1002/ijc.11164 · Cited by 61
Alsalameh, S., Burian, M., Mahr, G., Woodcock, B. G., & Geißlinger, G. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01460.x · Cited by 61
Dilger, K., Herrlinger, C., Peters, J., Seyberth, H. W., Schweer, H., & Klotz, U. E. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127000204200905 · Cited by 59
Bavbek, S., Çelík, G., Ediger, D., et al. (1999) · Journal of Asthma · doi:10.3109/02770909909055417 · Cited by 57
Sample, D., Wargovich, M. J., Fischer, S. M., Inamdar, N., Schwartz, P. E., Wang, X., Do, K.-A., & Sinicrope, F. A. (2002) · PubMed · Cited by 53
Coordinate Regulation of Prostaglandin Metabolism for Induction of Parturition in Mice
Winchester, S. K., Imamura, T., Gross, G. A., Muglia, L. M., Vogt, S. K., Wright, J., Watanabe, K., Tai, H., & Muglia, L. J. (2002) · Endocrinology · doi:10.1210/endo.143.7.8926 · Cited by 49
Rordorf, C. M., Kellett, N., Mair, S. J., Ford, M., Milosavljev, S., Branson, J., & Scott, G. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01691.x · Cited by 46
Korita, D., Sagawa, N., Itoh, H., Yura, S., Yoshida, M., Kakui, K., 竹村, 真., Yokoyama, C., Tanabe, T., & Fujii, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020531 · Cited by 46
Chow, L. W. C., Wong, J. L. N., & Toi, M. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00355-8 · Cited by 44
Thromboxane synthase: structure and function of protein and gene
Wang, L.-H., & Kulmacz, R. J. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00045-x · Cited by 43
Crane, C. H., Mason, K. A., Janjan, N. A., et al. (2003) · American Journal of Clinical Oncology · doi:10.1097/00000421-200308002-00009 · Cited by 41
Krishnan, K., Ruffin, M. T., Normolle, D. P., Shureiqi, I., Burney, K. D., Bailey, J., Peters-Golden, M. L., Rock, C. L., Boland, C. R., & Brenner, D. E. (2001) · PubMed · Cited by 35
Both Constitutive and Inducible Prostaglandin H Synthase Affect Dermal Wound Healing in Mice
Laulederkind, S. J. F., Thompson-Jaeger, S., Goorha, S., Chen, Q., Fu, A., Rho, J. Y., Ballou, L. R., & Raghow, R. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000020407.98665.98 · Cited by 31
Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?
Chioléro, A., Burnier, M., & Maillard, M. P. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.1.45 · Cited by 14
Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Cited by
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Antman, E. M., Bennett, J. S., Daugherty, A., Furberg, C., Roberts, H., & Taubert, K. A. (2007) · Circulation · doi:10.1161/circulationaha.106.181424 · Cited by 804
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
Grzanna, R., Lindmark, L., & Frondoza, C. G. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.125 · Cited by 778
Diclofenac: an update on its mechanism of action and safety profile
Gan, T. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.486301 · Cited by 600
Metadata
- Authors
- Warner, T. D., & Mitchell, J. A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 790-804
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2076744535
- Cited by
- 614
- References
- 135
- FWCI
- 35.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.